皮肤病与性病2024,Vol.46Issue(1) :19-23.DOI:10.3969/j.issn.1002-1310.2024.01.005

坏疽性脓皮病的发病机制及治疗进展

The pathogenesis and treatment progress of pyoderma gangrenosum

杨秋碧 周晓鸿 秦帆 李宜蔓
皮肤病与性病2024,Vol.46Issue(1) :19-23.DOI:10.3969/j.issn.1002-1310.2024.01.005

坏疽性脓皮病的发病机制及治疗进展

The pathogenesis and treatment progress of pyoderma gangrenosum

杨秋碧 1周晓鸿 1秦帆 1李宜蔓1
扫码查看

作者信息

  • 1. 昆明医科大学第二附属医院皮肤科,云南 昆明 650101
  • 折叠

摘要

坏疽性脓皮病是一种伴随罕见的疼痛性皮肤溃疡的嗜中性皮肤病.坏疽性脓皮病的发病机制复杂且尚未完全清楚,但目前研究表明其与中性粒细胞功能障碍、免疫功能失调、遗传易感性等有关.由于缺乏特异性生物标志物,坏疽性脓皮病的诊断难度较大,容易造成误诊,可根据Paracelsus评分诊断.目前坏疽性脓皮病的治疗以糖皮质激素和免疫抑制剂为主,生物制剂对坏疽性脓皮病的治疗具有广阔的应用前景.

Abstract

Pyoderma gangrenosum(PG)is a rare neutrophilic dermatosis that can cause painful skin ulcers.The pathogenesis of PG is complex and not yet fully understood,but current research has pointed out that it is related to neutrophil dysfunction,immune dysfunction,genetic susceptibility,etc.Due to the lack of specific biomarkers,the diagnosis of PG is difficult and prone to misdiagnosis,which can be diagnosed based on the PARACELSUS score.At present,the treatment of PG mainly relies on glucocorticoids and immunosuppressants,and biological agents have broad application prospects in the treatment of PG.

关键词

坏疽性脓皮病/发病机制/中性粒细胞/治疗

Key words

Pyoderma Gangrenosum/Pathogenesis/Neutrophil/Treatment

引用本文复制引用

出版年

2024
皮肤病与性病
中华医学会昆明分会

皮肤病与性病

影响因子:0.56
ISSN:1002-1310
参考文献量37
段落导航相关论文